drugset / Trial / NCT02137993
Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of A-prexa compared to Zyprexa in patients with schizophrenia, schizophreniform disorder and schizoaffective disorder.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | A-prexa | Unknown | 5 mg | — |
| Comparator | A-prexa | Unknown | 10 mg | — |
| Subject | Olanzapine | Small molecule | 5 mg | — |
| Subject | Olanzapine | Small molecule | 10 mg | — |